Monitoring regulatory T cells as a prognostic marker in lung transplantation
暂无分享,去创建一个
[1] K. Leung,et al. Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure , 2023, Blood advances.
[2] F. Claas,et al. Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation , 2022, Frontiers in Immunology.
[3] D. Kreisel,et al. Ischemia reperfusion injury facilitates lung allograft acceptance through IL‐33‐mediated activation of donor‐derived IL‐5 producing group 2 innate lymphoid cells , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] S. Kazmi,et al. Therapeutic nexus of T cell immunometabolism in improving transplantation immunotherapy. , 2022, International immunopharmacology.
[5] D. Broering,et al. CTLA4-Ig mediated immunosuppression favors immunotolerance and restores graft in mouse airway transplants. , 2022, Pharmacological research.
[6] S. Kazmi,et al. Targeting Interleukin-10 Restores Graft Microvascular Supply and Airway Epithelium in Rejecting Allografts , 2022, International journal of molecular sciences.
[7] M. Cutolo,et al. CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients , 2021, Arthritis Research & Therapy.
[8] Chuanming Wang,et al. Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor , 2021, Frontiers in Immunology.
[9] N. Pallet,et al. Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction , 2021, Nature Communications.
[10] S. Kazmi,et al. IL-10 Mediated Immunomodulation Limits Subepithelial Fibrosis and Repairs Airway Epithelium in Rejecting Airway Allografts , 2021, Cells.
[11] C. Takiya,et al. Adenosine Diphosphate Improves Wound Healing in Diabetic Mice Through P2Y12 Receptor Activation , 2021, Frontiers in Immunology.
[12] S. Keshavjee,et al. Ex vivo delivery of regulatory T-cells for control of alloimmune priming in the donor lung , 2021, European Respiratory Journal.
[13] M. Khan. Regulatory T cells mediated immunomodulation during asthma: a therapeutic standpoint , 2020, Journal of translational medicine.
[14] Josalyn L Cho,et al. Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung , 2020, Nature Immunology.
[15] M. Martelli,et al. CLINICAL-GRADE EXPANDED TREGS ARE ENRICHED WITH HIGHLY SUPPRESSIVE CELLS PRODUCING IL-10, GRANZYME B AND IL-35. , 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[16] H. Nishimasu,et al. Kidney GATA3+ regulatory T cells play roles in the convalescence stage after antibody-mediated renal injury , 2020, Cellular & Molecular Immunology.
[17] F. Borràs,et al. Potential of Extracellular Vesicle-Associated TSG-6 from Adipose Mesenchymal Stromal Cells in Traumatic Brain Injury , 2020, International journal of molecular sciences.
[18] R. Lechler,et al. The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology , 2020, Frontiers in Immunology.
[19] Hao Yang,et al. Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia , 2020, Journal of Neuroinflammation.
[20] Xiaochuan Wu,et al. CTLA4-Ig Abatacept Ameliorates Proteinuria by Regulating Circulating Treg/IL-17 in Adriamycin-Induced Nephropathy Rats , 2020, BioMed research international.
[21] G. Verleden,et al. Survival in adult lung transplantation: where are we in 2020? , 2020, Current opinion in organ transplantation.
[22] S. Kazmi,et al. Hypoxia-induced complement dysregulation is associated with microvascular impairments in mouse tracheal transplants , 2020, Journal of Translational Medicine.
[23] M. Butte,et al. The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis , 2020, Advances in wound care.
[24] Yu-Hua Li,et al. TSG-6 Inhibits Oxidative Stress and Induces M2 Polarization of Hepatic Macrophages in Mice With Alcoholic Hepatitis via Suppression of STAT3 Activation , 2020, Frontiers in Pharmacology.
[25] F. Carbone,et al. Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation , 2020, Frontiers in Immunology.
[26] N. Glaichenhaus,et al. Donor‐specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[27] R. Lechler,et al. Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[28] Xiaomin Song,et al. Foxp3 Post-translational Modifications and Treg Suppressive Activity , 2019, Front. Immunol..
[29] D. Broering,et al. iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants , 2019, Stem Cell Research & Therapy.
[30] M. Weyand,et al. Preservation of Microvascular Integrity in Murine Orthotopic Tracheal Allografts by Clopidogrel , 2019, Transplantation.
[31] D. Mueller. Faculty Opinions recommendation of DNA Demethylation of the Foxp3 Enhancer Is Maintained through Modulation of Ten-Eleven-Translocation and DNA Methyltransferases. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[32] M. Khan,et al. Complement factor and T‐cell interactions during alloimmune inflammation in transplantation , 2018, Journal of leukocyte biology.
[33] Ping Zhang,et al. Upregulated TSG-6 Expression in ADSCs Inhibits the BV2 Microglia-Mediated Inflammatory Response , 2018, BioMed Research International.
[34] Feifei Qiu,et al. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance , 2018, Front. Immunol..
[35] Yongliang Zhang,et al. 4-1BB enhancement of CAR T function requires NF-κB and TRAFs. , 2018, JCI insight.
[36] Mikaël M. Martino,et al. Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets. , 2018, Advances in wound care.
[37] A. Vater,et al. C5a Blockade Increases Regulatory T Cell Numbers and Protects Against Microvascular Loss and Epithelial Damage in Mouse Airway Allografts , 2018, Front. Immunol..
[38] M. Ansari,et al. A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants , 2018, Scientific Reports.
[39] P. Hopkins,et al. Accumulation of Intragraft CD15s+Tregs in Long-term Lung Transplant Survivors , 2018 .
[40] R. Girgis,et al. Individualizing immunosuppression in lung transplantation , 2018, Global cardiology science & practice.
[41] J. Madrigal,et al. Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies , 2018, Front. Immunol..
[42] K. Kretschmer,et al. Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation , 2018, Front. Immunol..
[43] S. Koba,et al. Emerging Roles of Tumor Necrosis Factor-Stimulated Gene-6 in the Pathophysiology and Treatment of Atherosclerosis , 2018, International journal of molecular sciences.
[44] C. Milner,et al. TSG-6: A multifunctional protein with anti-inflammatory and tissue-protective properties. , 2018, Matrix biology : journal of the International Society for Matrix Biology.
[45] T. Chatila,et al. Antigen-specific Treg cells in immunological tolerance: implications for allergic diseases , 2018, F1000Research.
[46] M. Ford,et al. Selective CD28 Blockade Results in Superior Inhibition of Donor‐Specific T Follicular Helper Cell and Antibody Responses Relative to CTLA4‐Ig , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[47] D. Kreisel,et al. Mechanisms of Graft Rejection and Immune Regulation after Lung Transplant , 2017, Annals of the American Thoracic Society.
[48] F. Pan,et al. The regulation of immune tolerance by FOXP3 , 2017, Nature Reviews Immunology.
[49] C. Tinelli,et al. Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients , 2017, BMC Pulmonary Medicine.
[50] F. Vincenti,et al. Transplant trials with Tregs: perils and promises. , 2017, The Journal of clinical investigation.
[51] C. van Kooten. Counteracting dysfunction of regulatory T cells in organ transplantation , 2017, Proceedings of the National Academy of Sciences.
[52] T. Welte,et al. Association of Higher CD4+CD25highCD127low, FoxP3+, and IL‐2+ T Cell Frequencies Early After Lung Transplantation With Less Chronic Lung Allograft Dysfunction at Two Years , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[53] R. Kumar,et al. IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154–CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized Mice , 2017, Front. Immunol..
[54] Sarah E. Ewald,et al. Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration , 2017, Front. Immunol..
[55] G. Opelz,et al. Helios expression and Foxp3 TSDR methylation of IFNy+ and IFNy- Treg from kidney transplant recipients with good long-term graft function , 2017, PloS one.
[56] P. P. Lee,et al. TSG-6 Downregulates IFN-Alpha and TNF-Alpha Expression by Suppressing IRF7 Phosphorylation in Human Plasmacytoid Dendritic Cells , 2017, Mediators of inflammation.
[57] F. Recillas-Targa,et al. Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients , 2017, Front. Immunol..
[58] R. Schmidt,et al. Harnessing the immunotherapeutic potential of T-lymphocyte co-signaling molecules in transplantation. , 2017, Immunology letters.
[59] L. Riella,et al. Treg‐Centric View of Immunosuppressive Drugs in Transplantation: A Balancing Act , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[60] J. Bluestone. FOXP3, the Transcription Factor at the Heart of the Rebirth of Immune Tolerance , 2017, The Journal of Immunology.
[61] T. Wekerle,et al. The Immunosuppressive Effect of CTLA4 Immunoglobulin Is Dependent on Regulatory T Cells at Low But Not High Doses , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[62] A. Malik,et al. TNFα-stimulated gene-6 (TSG6) activates macrophage phenotype transition to prevent inflammatory lung injury , 2016, Proceedings of the National Academy of Sciences of the United States of America.
[63] M. Khan. T regulatory Cell-mediated Immunotherapy for Solid Organ Transplantation: A Clinical Perspective , 2016, Molecular medicine.
[64] Q. Tang,et al. Impact of Immune-Modulatory Drugs on Regulatory T Cell , 2016, Transplantation.
[65] C. Bonorino,et al. IL-10 is required for polarization of macrophages to M2-like phenotype by mycobacterial DnaK (heat shock protein 70). , 2016, Cytokine.
[66] D. Onsager,et al. “Age” in lung transplantation: factors related to outcomes and other considerations , 2016, Current Pulmonology Reports.
[67] S. Todo,et al. A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation , 2016, Hepatology.
[68] S. FellahHSebbaghIChabniNBenyahiaDBenmeddah,et al. Onychomycosis: Pathogenesis and diagnosis , 2016 .
[69] P. Harden,et al. CD45RA Distinguishes CD4+CD25+CD127−/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression , 2016, Transplantation.
[70] Longlong Yang,et al. TSG-6 secreted by human umbilical cord-MSCs attenuates severe burn-induced excessive inflammation via inhibiting activations of P38 and JNK signaling , 2016, Scientific Reports.
[71] A. Bharat,et al. Lung Injury Combined with Loss of Regulatory T Cells Leads to De Novo Lung-Restricted Autoimmunity , 2016, The Journal of Immunology.
[72] L. Schaffer,et al. Regulatory T-cell–intrinsic amphiregulin is dispensable for suppressive function , 2016, Journal of Allergy and Clinical Immunology.
[73] Weiqi Wang,et al. Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity , 2016, Scientific Reports.
[74] A. J. Day,et al. The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions* , 2016, The Journal of Biological Chemistry.
[75] A. Abbas,et al. Cutting Edge: Regulatory T Cells Facilitate Cutaneous Wound Healing , 2016, The Journal of Immunology.
[76] J. Hsu,et al. Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective , 2016, Clinical and experimental immunology.
[77] A. MacLeod,et al. The Innate Immune System in Acute and Chronic Wounds , 2016, Advances in wound care.
[78] S. Fuller,et al. IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1 , 2015, The Journal of Immunology.
[79] Ling Zhao,et al. Inflammatory responses and inflammation-associated diseases in organs , 2015, Oncotarget.
[80] S. H. van der Burg,et al. Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry , 2015, Cancer Immunology, Immunotherapy.
[81] H. Otten,et al. Profiling of peripheral blood mononuclear cells does not accurately predict the bronchiolitis obliterans syndrome after lung transplantation. , 2015, Transplant immunology.
[82] W. Baldwin,et al. An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell suppressive function and therapeutic efficacy , 2015, Mucosal Immunology.
[83] Yoshiyuki Hizukuri,et al. IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration. , 2015, International immunology.
[84] A. Shaish,et al. Regulatory T cells influence blood flow recovery in experimental hindlimb ischaemia in an IL-10-dependent manner. , 2014, Cardiovascular research.
[85] O. Stojadinović,et al. Innate and Adaptive Immune Responses in Wound Epithelialization. , 2014, Advances in wound care.
[86] Yasmine Belkaid,et al. The Alarmin IL-33 Promotes Regulatory T Cell Function in the Intestine , 2014, Nature.
[87] W. Yue,et al. Prevention of acute liver allograft rejection by IL‐10‐engineered mesenchymal stem cells , 2014, Clinical and experimental immunology.
[88] T. Crombleholme,et al. Regenerative Wound Healing: The Role of Interleukin-10. , 2014, Advances in wound care.
[89] L. Dürselen,et al. TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds. , 2014, The Journal of investigative dermatology.
[90] S. Moeez,et al. T-regulatory cell-mediated immune tolerance as a potential immunotherapeutic strategy to facilitate graft survival. , 2013, Blood transfusion = Trasfusione del sangue.
[91] S. Klußmann,et al. Targeting complement component 5a promotes vascular integrity and limits airway remodeling , 2013, Proceedings of the National Academy of Sciences.
[92] N. Yoon,et al. TSG-6 Produced by hMSCs Delays the Onset of Autoimmune Diabetes by Suppressing Th1 Development and Enhancing Tolerogenicity , 2013, Diabetes.
[93] J. Tidball,et al. IL-10 Triggers Changes in Macrophage Phenotype That Promote Muscle Growth and Regeneration , 2012, The Journal of Immunology.
[94] L. Chiriboga,et al. Pharmacological blockade of adenosine A2A receptors diminishes scarring , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[95] W. Młynarski,et al. Administration of CD4+CD25highCD127− Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children , 2012, Diabetes Care.
[96] B. Hall,et al. IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity. , 2012, Blood.
[97] A. Rudensky,et al. Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.
[98] J. Lafaille,et al. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. , 2012, Annual review of immunology.
[99] S. Tseng,et al. TSG-6 controls transcription and activation of matrix metalloproteinase 1 in conjunctivochalasis. , 2012, Investigative ophthalmology & visual science.
[100] D. Tran. TGF-β: the sword, the wand, and the shield of FOXP3(+) regulatory T cells. , 2012, Journal of molecular cell biology.
[101] J. Bluestone,et al. CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. , 2012, Journal of molecular cell biology.
[102] M. Nicolls,et al. CD4+ T Cells and Complement Independently Mediate Graft Ischemia in the Rejection of Mouse Orthotopic Tracheal Transplants , 2011, Circulation Research.
[103] Napoleone Ferrara,et al. Developmental and pathological angiogenesis. , 2011, Annual review of cell and developmental biology.
[104] D. Campbell,et al. Treg cells: patrolling a dangerous neighborhood , 2011, Nature Medicine.
[105] D. Prockop,et al. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. , 2011, Blood.
[106] C. Larsen,et al. Regulatory T cells in lung transplantation—an emerging concept , 2011, Seminars in Immunopathology.
[107] H. Bakker,et al. Intravenous administration of recombinant human IL-10 suppresses the development of anti-thy 1-induced glomerulosclerosis in rats. , 2011, PDA journal of pharmaceutical science and technology.
[108] Stephanie R. Lochhead,et al. Interleukin-10 repletion suppresses pro-inflammatory cytokines and decreases liver pathology without altering viral replication in murine cytomegalovirus (MCMV)-infected IL-10 knockout mice , 2010, Inflammation Research.
[109] L. Molinero,et al. Decreased Percentage of CD4+FoxP3+ Cells in Bronchoalveolar Lavage From Lung Transplant Recipients Correlates With Development of Bronchiolitis Obliterans Syndrome , 2010, Transplantation.
[110] M. Gawaz,et al. Platelets in regeneration. , 2010, Seminars in thrombosis and hemostasis.
[111] Howard P. Greisler,et al. Molecular Mediators of Angiogenesis , 2010, Journal of burn care & research : official publication of the American Burn Association.
[112] A. Fietta,et al. Indoleamine 2,3-dioxygenase in lung allograft tolerance. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[113] Gisen Kim,et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.
[114] Arthur S Slutsky,et al. Functional Repair of Human Donor Lungs by IL-10 Gene Therapy , 2009, Science Translational Medicine.
[115] A. Kirk,et al. Dynamics of Human Regulatory T Cells in Lung Lavages of Lung Transplant Recipients , 2009, Transplantation.
[116] P. Delafontaine,et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. , 2009, Cell stem cell.
[117] T. Nomura,et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. , 2009, Immunity.
[118] S. Bhorade,et al. Immunosuppression for lung transplantation. , 2009, Proceedings of the American Thoracic Society.
[119] Xuehai Zhu,et al. CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients. , 2008, American journal of respiratory and critical care medicine.
[120] T. Wilgus,et al. Immune cells in the healing skin wound: influential players at each stage of repair. , 2008, Pharmacological research.
[121] M. Reynaud‐Gaubert,et al. CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients , 2008, European Respiratory Journal.
[122] A. Scheffold,et al. IL‐2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells , 2008, European journal of immunology.
[123] O. Yang,et al. Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection. , 2008, Transplantation.
[124] M. Reynaud‐Gaubert,et al. T Regulatory Cells in Stable Posttransplant Bronchiolitis Obliterans Syndrome , 2007, Transplantation.
[125] R. Thrall,et al. Accumulation of Regulatory T Cells in Local Draining Lymph Nodes of the Lung Correlates with Spontaneous Resolution of Chronic Asthma in a Murine Model , 2007, International Archives of Allergy and Immunology.
[126] F. Powrie,et al. Emerging Challenges in Regulatory T Cell Function and Biology , 2007, Science.
[127] M. Roncarolo,et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. , 2007, International immunology.
[128] T. Huizinga,et al. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells , 2007, European journal of immunology.
[129] R. Lechler,et al. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance. , 2006, Transplantation proceedings.
[130] J. Ritz,et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. , 2006, Blood.
[131] A. Bharat,et al. CD4+25+ Regulatory T Cells Limit Th1‐Autoimmunity by Inducing IL‐10 Producing T Cells Following Human Lung Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[132] Christopher H Contag,et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. , 2006, Blood.
[133] A. Rudensky,et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[134] C. Hawrylowicz. Regulatory T cells and IL-10 in allergic inflammation , 2005, The Journal of experimental medicine.
[135] S. Sakaguchi. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.
[136] A. Singer,et al. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2 , 2005, Nature Immunology.
[137] A. O’Garra,et al. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. , 2004, The Journal of clinical investigation.
[138] A. Fietta,et al. Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome , 2004, Transplantation.
[139] M. Fishbein,et al. Regulated interleukin-10 expression prevents chronic rejection of transplanted hearts. , 2003, The Journal of thoracic and cardiovascular surgery.
[140] S. Werner,et al. Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.
[141] C. Milner,et al. TSG-6: a multifunctional protein associated with inflammation , 2003, Journal of Cell Science.
[142] Marilyn S. Rugg,et al. The Link Module from Human TSG-6 Inhibits Neutrophil Migration in a Hyaluronan- and Inter-α-inhibitor-independent Manner* , 2002, The Journal of Biological Chemistry.
[143] Ethan M. Shevach,et al. CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor β1 Production and Responsiveness , 2002, The Journal of experimental medicine.
[144] A. Boehler. The role of interleukin-10 in lung transplantation. , 2002, Transplant immunology.
[145] F. Powrie,et al. IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo1 , 2001, The Journal of Immunology.
[146] Milton W. Taylor,et al. Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell Proliferation , 2000, The Journal of Immunology.
[147] D. Broering,et al. FOXP3+ regulatory T cell ameliorates microvasculature in the rejection of mouse orthotopic tracheal transplants. , 2017, Clinical immunology.
[148] R. Sobel,et al. Aspergillus Invasion Increases with Progressive Airway Ischemia , 2014 .
[149] M. Nicolls,et al. Complement-mediated microvascular injury leads to chronic rejection. , 2013, Advances in experimental medicine and biology.
[150] J. Albina,et al. Wound macrophages as key regulators of repair: origin, phenotype, and function. , 2011, The American journal of pathology.
[151] Marshall I Hertz,et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[152] H. Waldmann,et al. Regulatory T cells in transplantation tolerance. , 2005, Current topics in microbiology and immunology.
[153] M. Goddard,et al. Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[154] S. Khoury,et al. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. , 2000, The Journal of clinical investigation.